Montreal, QC, September 24, 2018 - MEDISCA, a global leader in the pharmaceutical compounding industry, strives to proactively strengthen their quality systems and adhere to regulatory requirements and enforcement.
The company continues to work diligently with Health Canada and has reintroduced over 140 Active Pharmaceutical Ingredients back into the market, while meeting regulatory requirements and avoiding further shortages in the industry.
As regulatory bodies enforce requirements globally, as seen in recent U.S. regulatory inspections, MEDISCA wants to reaffirm its commitment to quality. To ensure that MEDISCA’s products adhere to the highest standards, the company utilizes a robust quality management system called MasterControl, which is highly recognized by regulatory agencies and has been used over several years to ensure effective management of quality systems. MEDISCA applies both validated electronic systems as well as physical segregation of material within our facilities to ensure quarantined, rejected, returned, or recalled material is held in quarantine status allowing only authorized quality personnel to determine final material disposition and ensuring the public is protected from unauthorized use of products.
Additionally, MEDISCA continues to apply a strong vendor qualification program and continues to invest heavily in our testing requirements, as quality is of utmost value to the industry. All chemicals undergo full compendial testing based on the latest compendiums to ensure manufacturers continue to supply MEDISCA with the highest standards of quality products. MEDISCA’s certificates of analysis allow for transparency of information to customers and reflect the testing requirements performed by MEDISCA along with relevant manufacturer information.
MEDISCA reiterates its commitment to quality and to their vision; to be the most reliable turnkey solutions provider for the compounding pharmacy community.
Anna Di Nezza Vanessa Verni
Director of Quality Director of Regulatory & Legal Affairs
MEDISCA is the leader in providing turnkey solutions to the pharmaceutical compounding industry and allied health care professionals worldwide. Through its global partners, LP3 Network and MEDISCA Network, MEDISCA is committed to being a complete resource for prescribers, pharmacists and pharmacy technicians engaged in personalized medicine by offering educational trainings, products, and support. Founded in 1989, the company has locations in Canada, the United States and Australia, optimizing its service to the international market. For more information about MEDISCA, please visit www.medisca.com and follow us on Twitter at @medisca.